This HTML5 document contains 48 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n11http://dx.doi.org/10.1161/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q71079024
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована в березні 1996 wetenschappelijk artikel im März 1996 veröffentlichter wissenschaftlicher Artikel artículu científicu espublizáu en marzu de 1996 scientific article published on 01 March 1996
p:P577
wds:Q71079024-F865D5A3-A541-4FF1-B373-035DDEB2865B
wdt:P577
1996-03-01T00:00:00Z
p:P2093
wds:Q71079024-49F68D17-981F-4A85-95CC-C06743222859 wds:Q71079024-0CD8D60A-8688-4C52-B6E6-ED77F014F0A4 wds:Q71079024-AEEE7990-E711-43C2-A1C6-C6DA6BC71F0B wds:Q71079024-FB3F1932-EE02-4DDC-9BEF-2979CCEE00E1 wds:Q71079024-8303289F-2D4A-47F0-80F8-7D438559BC04 wds:Q71079024-A4D2CE67-01DB-4B9B-B42D-26CF7D54AA9A wds:Q71079024-9EA5650F-87FA-43C5-BAA2-5A16C0806B7D
wdt:P2093
J W Jukema J H Reiber A V Bruschke A J van Boven A Van der Laarse K I Lie A H Zwinderman
rdfs:label
Evidence for a synergistic effect of calcium channel blockers with lipid-lowering therapy in retarding progression of coronary atherosclerosis in symptomatic patients with normal to moderately raised cholesterol levels. The REGRESS Study Group Evidence for a synergistic effect of calcium channel blockers with lipid-lowering therapy in retarding progression of coronary atherosclerosis in symptomatic patients with normal to moderately raised cholesterol levels. The REGRESS Study Group
skos:prefLabel
Evidence for a synergistic effect of calcium channel blockers with lipid-lowering therapy in retarding progression of coronary atherosclerosis in symptomatic patients with normal to moderately raised cholesterol levels. The REGRESS Study Group Evidence for a synergistic effect of calcium channel blockers with lipid-lowering therapy in retarding progression of coronary atherosclerosis in symptomatic patients with normal to moderately raised cholesterol levels. The REGRESS Study Group
schema:name
Evidence for a synergistic effect of calcium channel blockers with lipid-lowering therapy in retarding progression of coronary atherosclerosis in symptomatic patients with normal to moderately raised cholesterol levels. The REGRESS Study Group Evidence for a synergistic effect of calcium channel blockers with lipid-lowering therapy in retarding progression of coronary atherosclerosis in symptomatic patients with normal to moderately raised cholesterol levels. The REGRESS Study Group
p:P1476
wds:Q71079024-71750A82-5B8D-44C7-B9A5-E6EBA4B0781C
wdt:P1476
Evidence for a synergistic effect of calcium channel blockers with lipid-lowering therapy in retarding progression of coronary atherosclerosis in symptomatic patients with normal to moderately raised cholesterol levels. The REGRESS Study Group
p:P304
wds:Q71079024-D5DAF731-2B27-4DDF-A532-0824A177AF6A
wdt:P304
425-430
p:P31
wds:Q71079024-AC473492-6372-46A8-9CF4-B43141399A09
wdt:P31
wd:Q13442814
p:P921
wds:Q71079024-70873AA1-BB77-4350-ACEC-E348215F5033
wdt:P921
wd:Q844935
p:P698
wds:Q71079024-1A7607C0-359D-40ED-A29E-2EBD98D1BDE4
wdtn:P698
n12:8630669
wdt:P698
8630669
p:P1433
wds:Q71079024-90A46E3D-FEE5-4365-8693-D388AB71C688
wdt:P1433
wd:Q4797542
p:P433
wds:Q71079024-9F353C64-195E-42AB-888E-A2B6693C19DF
p:P478
wds:Q71079024-11CDD038-88DD-4A98-881D-0F5402C1378A
wdt:P433
3
wdt:P478
16
p:P356
wds:Q71079024-ABF1730D-FCAC-4CA2-AFEB-720D404C7490
wdtn:P356
n11:01.ATV.16.3.425
wdt:P356
10.1161/01.ATV.16.3.425